Stock VRTX VERTEX PHARMACEUTICALS INCORPORATED
Add to a list
To use this feature you must be a member
Log inSign up

Funds and ETFs Vertex Pharmaceuticals Incorporated

Equities

VRTX

US92532F1003

Biotechnology & Medical Research

Real-time Estimate Cboe BZX
Other stock markets
 15:35:15 23/05/2024 BST 		5-day change 1st Jan Change
449.8 USD +0.51% Intraday chart for Vertex Pharmaceuticals Incorporated +2.10% +10.57%
05-22 Vertex Pharmaceuticals Insider Sold Shares Worth $6,795,294, According to a Recent SEC Filing MT
05-21 ADDvise Group’s Axelerist Bags $1.4 Million Order for Medical, Lab Equipment MT

ETFs positioned on Vertex Pharmaceuticals Incorporated

Name Weight AuM 1st Jan change Investor Rating
AMUNDI INDEX MSCI NORTH AMERICA ESG BROAD CTB UCITS ETF DR (C) - EUR ETF Amundi Index MSCI North America ESG Broad CTB UCITS ETF DR (C) - EUR
0.13% 322 M€ +13.88% -
AMUNDI INDEX MSCI NORTH AMERICA ESG BROAD CTB UCITS ETF DR (D) - EUR ETF Amundi Index MSCI North America ESG Broad CTB UCITS ETF DR (D) - EUR
0.13% 29 M€ -.--% -
FRANKLIN LIBERTY CORE BALANCED ETF - DISTRIBUTING - CAD ETF Franklin Liberty Core Balanced ETF - Distributing - CAD
0.13% 1 M€ +3.03% -
VANGUARD LIFESTRATEGY 80% EQUITY UCITS ETF - DISTRIBUTING - EUR ETF Vanguard LifeStrategy 80% Equity UCITS ETF - Distributing - EUR
0.12% 34 M€ +9.41% -
HARTFORD DISCIPLINED US EQUITY ETF - USD ETF Hartford Disciplined US Equity ETF - USD
0.11% 104 M€ +10.51%
VANGUARD LIFESTRATEGY 80% EQUITY UCITS ETF ACC - EUR ETF Vanguard LifeStrategy 80% Equity UCITS ETF Acc - EUR
0.11% 391 M€ +9.34% -
RAREVIEW SYSTEMATIC EQUITY ETF - USD ETF Rareview Systematic Equity ETF - USD
0.09% 45 M€ 0.00% -
VANGUARD LIFESTRATEGY 60% EQUITY UCITS ETF - ACC - EUR ETF Vanguard LifeStrategy 60% Equity UCITS ETF - Acc - EUR
0.09% 306 M€ +6.36% -
VANGUARD LIFESTRATEGY 60% EQUITY UCITS ETF - DISTRIBUTING - EUR ETF Vanguard LifeStrategy 60% Equity UCITS ETF - Distributing - EUR
0.09% 39 M€ +6.13% -
STRATEGY SHARES NASDAQ 7HANDL INDEX ETF - USD ETF Strategy Shares Nasdaq 7HANDL Index ETF - USD
0.08% 756 M€ +0.77% -
STRATEGY SHARES NASDAQ 5HANDL INDEX ETF - USD ETF Strategy Shares Nasdaq 5HANDL Index ETF - USD
0.08% 2 M€ +3.16% -
RH TACTICAL ROTATION ETF - USD ETF RH Tactical Rotation ETF - USD
0.06% 12 M€ +16.31% -
IQ REAL RETURN ETF - USD ETF IQ Real Return ETF - USD
0.05% 6 M€ +3.89%
VANGUARD LIFESTRATEGY 40% EQUITY UCITS ETF ACC - EUR ETF Vanguard LifeStrategy 40% Equity UCITS ETF Acc - EUR
0.05% 105 M€ +3.80% -
VANGUARD LIFESTRATEGY 40% EQUITY UCITS ETF - DISTRIBUTING - EUR ETF Vanguard LifeStrategy 40% Equity UCITS ETF - Distributing - EUR
0.05% 17 M€ +3.49% -
LEADERSHARES EQUITY SKEW ETF - USD ETF LeaderShares Equity Skew ETF - USD
0.04% 112 M€ +4.91% -
GOOSE HOLLOW TACTICAL ALLOCATION ETF - USD ETF Goose Hollow Tactical Allocation ETF - USD
0.04% 32 M€ +2.17% -
VANGUARD LIFESTRATEGY 20% EQUITY UCITS ETF ACC - EUR ETF Vanguard LifeStrategy 20% Equity UCITS ETF Acc - EUR
0.03% 54 M€ +0.97% -
VANGUARD LIFESTRATEGY 20% EQUITY UCITS ETF - DISTRIBUTING - EUR ETF Vanguard LifeStrategy 20% Equity UCITS ETF - Distributing - EUR
0.03% 8 M€ +0.94% -
ADAPTIVE GROWTH OPPORTUNITIES ETF - USD ETF Adaptive Growth Opportunities ETF - USD
0.02% 234 M€ +6.83% -
CABANA TARGET DRAWDOWN 5 ETF - USD ETF Cabana Target Drawdown 5 ETF - USD
0.02% 6 M€ -4.26% -
CABANA TARGET LEADING SECTOR MODERATE ETF - USD ETF Cabana Target Leading Sector Moderate ETF - USD
0.01% 169 M€ +0.80% -
NEXT FUNDS S&P 500 ETF - JPY HEDGED ETF NEXT FUNDS S&P 500 ETF - JPY Hedged
7.21% 129 M€ +8.90% -
NEXT FUNDS NASDAQ-100(R) (YEN-HEDGED) - JPY HEDGED ETF NEXT FUNDS NASDAQ-100(R) (Yen-Hedged) - JPY Hedged
8.05% 28 M€ +8.95% -
2345

Company Profile

Vertex Pharmaceuticals Incorporated specializes in the research, development and marketing of micromolecular drugs primarily for the treatment of cancers, viral, inflammatory and auto-immune diseases. Net sales are distributed geographically as follows: the United States (61.2%), Europe (31.5%) and other (7.3%).
Sector
Biotechnology & Medical Research
Calendar
31/07/2024 - Q2 2024 Earnings Release (Projected)
Related indices
S&P 500
More about the company

Income Statement Evolution

More financial data

Ratings for Vertex Pharmaceuticals Incorporated

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
32
Last Close Price
447.5 USD
Average target price
462.8 USD
Spread / Average Target
+3.41%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Bio Therapeutic Drugs

1st Jan change Capi.
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
+10.57% 115B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
+12.40% 106B
BIONTECH SE Stock BioNTech SE
-5.72% 24.69B
ARGENX SE Stock argenx SE
-1.46% 21.97B
GENMAB A/S Stock Genmab A/S
-4.87% 19.27B
BEIGENE, LTD. Stock BeiGene, Ltd.
-11.04% 17.56B
WUXI APPTEC CO., LTD. Stock WuXi AppTec Co., Ltd.
-39.36% 17.32B
NEUROCRINE BIOSCIENCES, INC. Stock Neurocrine Biosciences, Inc.
+5.95% 14.03B
SAREPTA THERAPEUTICS, INC. Stock Sarepta Therapeutics, Inc.
+33.58% 12.13B
LEGEND BIOTECH CORPORATION Stock Legend Biotech Corporation
-31.33% 7.77B
Bio Therapeutic Drugs
  1. Stock Market
  2. Equities
  3. VRTX Stock
  4. Funds and ETFs Vertex Pharmaceuticals Incorporated